Search results
HPV infection and HIV acquisition in women. Averbach[], Low[] and Smith-McCune[] et al increased risk of HIV acquisition associated with infection with any HPV genotype compared to no HPV infection in women.The point estimate from all three were consistent with a harmful effect of HPV infection (aHR=1.71, aHR=2.40 and aHR=2.26 respectively) although the association was only statistically ...
- HPV and the Risk of HIV Acquisition in Women - PMC - PubMed Central (PMC)
The ability of HPV to establish a chronic infection within...
- HPV and the Risk of HIV Acquisition in Women - PMC - PubMed Central (PMC)
Suggestions of a higher risk to contract HIV if there is existing genital HPV infection are supported and explained by pathophysiological cervical changes, including inflammation.
1 lut 2018 · HIV–HPV interactions should influence public health decisions towards prioritising large-scale prepubertal HPV vaccination, secondary cervical cancer prevention by screening and early detection programmes for HIV-infected women to complement early initiation of ART.
5 cze 2018 · Observational studies suggest HIV and human papillomavirus (HPV) infections may have multiple interactions. We reviewed the strength of the evidence for the influence of HIV on HPV acquisition and clearance, and the influence of HPV on HIV acquisition. Methods.
The ability of HPV to establish a chronic infection within the genital mucosal epithelium has implications on HIV acquisition risk and prevention strategies, and remains an area of active research, in particular with novel therapeutic vaccines reaching trial stages in 2021 (Ayesha et al., 2021).
HIV-positive women had higher risk of acquiring infection with any HPV (RR pooled 2.64, 95% CI 2.04–3.42), as well as high risk (HR) HPV, HPV 16, and HPV 18 (RR pooled 2.35, 95% CI 1.64–3.37; RR pooled 3.05, 95% CI 1.71–5.42; RR pooled 2.55, 95% CI 1.17–5.60, respectively) .
18 sty 2024 · Abstract. Background. Women living with HIV (WLWH) are at increased risk of human papillomavirus (HPV)-related cancers. Throughout Europe, there is great heterogeneity among guidelines for screening programmes, access to HPV testing and HPV vaccination.